Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedAug 23, 2025
DataAggregated Company Financials
Companies5
  • 7D11.5%
  • 3M-16.7%
  • 1Y-58.9%
  • YTD-41.6%

In the last week, the Pharma industry is up 9.5%, with all of the companies up. In contrast, the industry has lost 60% in the last 12 months. Looking forward, earnings are forecast to grow by 9.3% annually.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 23 Aug 2025DKK 1.7tDKK 341.3bDKK 115.5b14.6x14.7x5x
Mon, 21 Jul 2025DKK 1.9tDKK 331.8bDKK 108.8b17.6x17.6x5.8x
Wed, 18 Jun 2025DKK 2.2tDKK 331.8bDKK 108.8b20.7x20.6x6.8x
Fri, 16 May 2025DKK 2.0tDKK 331.8bDKK 108.8b18.4x18.4x6x
Sun, 13 Apr 2025DKK 1.9tDKK 317.9bDKK 104.9b18.5x18.3x6.1x
Tue, 11 Mar 2025DKK 2.5tDKK 317.9bDKK 104.9b24.1x23.9x7.9x
Thu, 06 Feb 2025DKK 2.7tDKK 297.4bDKK 98.1b29x27.6x9.1x
Sat, 04 Jan 2025DKK 2.9tDKK 297.4bDKK 98.2b29.9x29.6x9.8x
Mon, 02 Dec 2024DKK 3.4tDKK 297.4bDKK 98.2b35.4x34.9x11.5x
Wed, 30 Oct 2024DKK 3.5tDKK 283.9bDKK 93.2b37.9x37.4x12.3x
Fri, 27 Sep 2024DKK 3.8tDKK 283.9bDKK 93.2b41.2x40.6x13.3x
Sun, 25 Aug 2024DKK 4.1tDKK 283.9bDKK 93.2b45x44.3x14.5x
Tue, 23 Jul 2024DKK 4.1tDKK 269.3bDKK 92.2b45.2x44.5x15.2x
Thu, 20 Jun 2024DKK 4.5tDKK 269.3bDKK 92.2b49.1x48.3x16.5x
Sat, 18 May 2024DKK 4.1tDKK 269.3bDKK 92.2b45.1x44.4x15.2x
Mon, 15 Apr 2024DKK 4.0tDKK 257.0bDKK 86.4b46.9x46.1x15.5x
Wed, 13 Mar 2024DKK 4.1tDKK 257.0bDKK 86.4b48.8x47.9x16.1x
Fri, 09 Feb 2024DKK 3.7tDKK 257.0bDKK 86.4b43.3x42.6x14.3x
Sun, 07 Jan 2024DKK 3.3tDKK 238.8bDKK 78.2b43x42.1x13.8x
Tue, 05 Dec 2023DKK 3.1tDKK 238.8bDKK 78.2b41x40.2x13.1x
Thu, 02 Nov 2023DKK 3.1tDKK 225.4bDKK 70.1b45.7x43.9x13.7x
Sat, 30 Sep 2023DKK 2.9tDKK 225.4bDKK 70.1b42.8x41.9x13x
Mon, 28 Aug 2023DKK 2.9tDKK 225.4bDKK 70.1b42.5x41.6x12.9x
Wed, 26 Jul 2023DKK 2.5tDKK 211.8bDKK 63.8b40x39.1x11.8x
Fri, 23 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b39.8x38.9x11.7x
Sun, 21 May 2023DKK 2.6tDKK 211.8bDKK 63.8b42.2x41.3x12.5x
Tue, 18 Apr 2023DKK 2.7tDKK 199.9bDKK 57.8b60.3x46.4x13.4x
Thu, 16 Mar 2023DKK 2.3tDKK 199.7bDKK 57.8b40.2x39.6x11.4x
Sat, 11 Feb 2023DKK 2.2tDKK 199.7bDKK 57.8b39.3x38.7x11.2x
Mon, 09 Jan 2023DKK 2.2tDKK 189.2bDKK 54.7b41.4x40.8x11.8x
Wed, 07 Dec 2022DKK 2.1tDKK 189.2bDKK 54.7b38.3x37.8x10.9x
Fri, 04 Nov 2022DKK 2.0tDKK 178.4bDKK 52.1b38.5x38.3x11.2x
Sun, 02 Oct 2022DKK 1.8tDKK 178.4bDKK 52.1b34.1x34.1x9.9x
Tue, 30 Aug 2022DKK 1.9tDKK 178.4bDKK 52.1b36x36.1x10.5x
Price to Earnings Ratio

36.1x


Total Market Cap: DKK 1.9tTotal Earnings: DKK 52.1bTotal Revenue: DKK 178.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 36.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.4x which is lower than its 3-year average PE of 36.7x.
  • The 3-year average PS ratio of 11.6x is higher than the industry's current PS ratio of 4.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 30% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market5.65%
Healthcare10.08%
Pharma11.49%
Pharma11.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 363.9011.7%
+DKK 168.9b		-60.1%PE14.6x
ALK B ALK-AbellóDKK 209.0014.2%
+DKK 5.8b		15.6%PE46.3x
HLUN B H. LundbeckDKK 39.882.1%
+DKK 812.8m		-13.8%PE11.3x
STENO StenocareDKK 0.8725.8%
+DKK 6.8m		-67.4%PS17.8x
PEG Pharma Equity GroupDKK 0.144.0%
+DKK 6.8m		-41.7%PB4.5x

Latest News

ALK B
DKK 209.00
ALK-Abelló
7D
14.2%
1Y
15.6%

Allergy+ Strategy Will Reach Millions With New Therapies

The increase in ALK-Abelló’s analyst price target is primarily driven by a modest upward revision in consensus revenue growth forecasts, while net profit margins remain steady, resulting in a new fair value estimate of DKK192.33 per share. What's in the News ALK-Abelló raised its 2025 revenue growth guidance to 12-14% (from 9-13%) in local currencies, supported by strong adrenaline autoinjector and tablet sales in Europe and North America, and will allocate additional funds to strategic growth investments.
NOVO B
DKK 363.90
Novo Nordisk
7D
11.7%
1Y
-60.1%
PEG
DKK 0.14
Pharma Equity Group
7D
4.0%
1Y
-41.7%

Here's Why Pharma Equity Group (CPH:PEG) Can Afford Some Debt

Aug 18
Here's Why Pharma Equity Group (CPH:PEG) Can Afford Some Debt
HLUN B
DKK 39.88
H. Lundbeck
7D
2.1%
1Y
-13.8%

The H. Lundbeck A/S (CPH:HLUN B) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 16
The H. Lundbeck A/S (CPH:HLUN B) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
STENO
DKK 0.87
Stenocare
7D
25.8%
1Y
-67.4%